J J Guex

Summary

Country: France

Publications

  1. ncbi Quality of life improvement in Latin American patients suffering from chronic venous disorder using a combination of Ruscus aculeatus and hesperidin methyl-chalcone and ascorbic acid (quality study)
    J J Guex
    Cabinet de Phlebologie, 32 Boulevard Dubouchage, Nice, France
    Int Angiol 29:525-32. 2010
  2. ncbi Importance of patient-reported outcomes in chronic venous disorders
    J J Guex
    Cabinet de Phlebologie, 32 Boulevard Dubouchage, Nice, France
    Phlebology 27:136-8. 2012
  3. ncbi The patient's burden of chronic venous disorders: construction of a questionnaire
    J J Guex
    Cabinet de Phlebologie, 32 Bd Dubouchage, 06000 Nice, France
    Phlebology 25:280-5. 2010
  4. ncbi Complications of sclerotherapy: an update
    Jean Jerome Guex
    Cabinet de Phleblogie, Nice, France
    Dermatol Surg 36:1056-1063. 2010
  5. ncbi Complications and side-effects of foam sclerotherapy
    J J Guex
    Cabinet de Médecine Vasculaire, 32 Bd Dubouchage, 06000 Nice, France
    Phlebology 24:270-4. 2009
  6. ncbi Immediate and midterm complications of sclerotherapy: report of a prospective multicenter registry of 12,173 sclerotherapy sessions
    Jean Jerome Guex
    Société Française de Phlébologie, Paris, France
    Dermatol Surg 31:123-8; discussion 128. 2005
  7. ncbi Correlations between ankle circumference, symptoms, and quality of life demonstrate the clinical relevance of minimal leg swelling reduction: results of a study in 1,036 Argentinean patients
    Jean Jerome Guex
    Cabinet de Phlebologie, Medecine vasculaire, Nice, France
    Dermatol Surg 34:1666-75. 2008
  8. ncbi Construction and validation of a patient-reported outcome dedicated to chronic venous disorders: SQOR-V (specific quality of life and outcome response - venous)
    J J Guex
    J Mal Vasc 32:135-47. 2007
  9. ncbi [Contra indications of sclerotherapy, update 2005]
    J J Guex
    J Mal Vasc 30:144-9. 2005
  10. ncbi Foam sclerotherapy: an overview of use for primary venous insufficiency
    Jean Jerome Guex
    Phlebology and Vascular Laboratory, Président Société Française de Phlébologie, Nice, France
    Semin Vasc Surg 18:25-9. 2005

Detail Information

Publications12

  1. ncbi Quality of life improvement in Latin American patients suffering from chronic venous disorder using a combination of Ruscus aculeatus and hesperidin methyl-chalcone and ascorbic acid (quality study)
    J J Guex
    Cabinet de Phlebologie, 32 Boulevard Dubouchage, Nice, France
    Int Angiol 29:525-32. 2010
    ..The present study assessed the effect of Ruscus aculeatus, hesperidin methyl-chalcone and ascorbic acid (HMC-AA), in the treatment of chronic venous disorders (CVD) in Latin American patients...
  2. ncbi Importance of patient-reported outcomes in chronic venous disorders
    J J Guex
    Cabinet de Phlebologie, 32 Boulevard Dubouchage, Nice, France
    Phlebology 27:136-8. 2012
    ..The author describes and compares a number of different methods currently in use for this purpose...
  3. ncbi The patient's burden of chronic venous disorders: construction of a questionnaire
    J J Guex
    Cabinet de Phlebologie, 32 Bd Dubouchage, 06000 Nice, France
    Phlebology 25:280-5. 2010
    ..On the other hand, it aims at reporting initial epidemiological and demographic data in CVD patients and their correlations...
  4. ncbi Complications of sclerotherapy: an update
    Jean Jerome Guex
    Cabinet de Phleblogie, Nice, France
    Dermatol Surg 36:1056-1063. 2010
    ..To describe, determine the incidence of, and explain the adverse reactions associated with the use of sclerotherapy and sclerosing agents...
  5. ncbi Complications and side-effects of foam sclerotherapy
    J J Guex
    Cabinet de Médecine Vasculaire, 32 Bd Dubouchage, 06000 Nice, France
    Phlebology 24:270-4. 2009
    ..To explain, when possible, their pathophysiology and to indicate possible manoeuvres and techniques to limit them...
  6. ncbi Immediate and midterm complications of sclerotherapy: report of a prospective multicenter registry of 12,173 sclerotherapy sessions
    Jean Jerome Guex
    Société Française de Phlébologie, Paris, France
    Dermatol Surg 31:123-8; discussion 128. 2005
    ..Growing interest in sclerotherapy has emphasized the need for complete knowledge of all aspects of this method...
  7. ncbi Correlations between ankle circumference, symptoms, and quality of life demonstrate the clinical relevance of minimal leg swelling reduction: results of a study in 1,036 Argentinean patients
    Jean Jerome Guex
    Cabinet de Phlebologie, Medecine vasculaire, Nice, France
    Dermatol Surg 34:1666-75. 2008
    ..Previous studies of venoactive drugs have demonstrated significant reduction in leg volume, but the correlation with a clinical improvement was lacking...
  8. ncbi Construction and validation of a patient-reported outcome dedicated to chronic venous disorders: SQOR-V (specific quality of life and outcome response - venous)
    J J Guex
    J Mal Vasc 32:135-47. 2007
    ....
  9. ncbi [Contra indications of sclerotherapy, update 2005]
    J J Guex
    J Mal Vasc 30:144-9. 2005
    ..Like all other techniques it should be employed in the safest, precisely described and reproducible conditions. Therefore, its contra indications must be clearly known...
  10. ncbi Foam sclerotherapy: an overview of use for primary venous insufficiency
    Jean Jerome Guex
    Phlebology and Vascular Laboratory, Président Société Française de Phlébologie, Nice, France
    Semin Vasc Surg 18:25-9. 2005
    ..Evaluation of long-term results, with regard to comparison with other techniques, should take into account all advantages and drawbacks and evaluate cost-effectiveness from a life-long point of view...
  11. ncbi Assessment of quality of life in Mexican patients suffering from chronic venous disorder - impact of oral Ruscus aculeatus-hesperidin-methyl-chalcone-ascorbic acid treatment - 'QUALITY Study'
    J J Guex
    Cabinet de Phlebologie, 32 Boulevard Dubouchage, 06000 Nice, France
    Phlebology 24:157-65. 2009
    ..The present study assessed the effect of Ruscus aculeatus-hesperidin-methyl-chalcone-ascorbic acid (HMC-AA) on the quality of life (QoL) of patients suffering from chronic venous disorders (CVDs)...
  12. ncbi Chronic venous disease: health status of a population and care impact on this health status through quality of life questionnaires
    J J Guex
    Société Française de Phlébologie, Nice, France
    Int Angiol 24:258-64. 2005
    ..The aims of the study were to describe the health status of female patients suffering from CVD, and to assess the care impact through QoL questionnaires...